Study investigates the gut microbiome’s role in Parkinson’s disease patients with mild cognitive impairments, revealing no distinct microbiome signatures associated with MCI in PD compared to cognitively normal PD patients or controls.
Researchers compared the associations of sedentary and physical activities with factors such as body fat.
In two phase III trials (ADvocate1 and ADvocate2), adult and adolescent patients with moderate-to-severe atopic dermatitis (AD) maintained similar improvements with investigational lebrikizumab at 1